STOCK TITAN

Natera: Caraluna trusts sell 1,500 common shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Natera, Inc. (NTRA) director and co-founder Jonathan Sheena reported that Caraluna 1 Trust and Caraluna 2 Trust sold 1,500 Natera common shares on November 11, 2026, under a Rule 10b5-1 trading plan adopted June 11, 2026. The shares were held for the trusts’ beneficiaries, and Sheena disclaimed beneficial ownership. A separate holding entry lists 214,462 shares held directly by Sheena following the reported transactions.

Insider Sheena Jonathan
Role Director
Sold 1,500 shs ($479K)
Type Security Shares Price Value
Sale Common Stock F1, F2 40 $315.26 $13K
Sale Common Stock F1, F3, F2 85 $316.9256 $27K
Sale Common Stock F1, F4, F2 145 $317.8748 $46K
Sale Common Stock F1, F5, F2 240 $319.7733 $77K
Sale Common Stock F1, F6, F2 160 $320.0188 $51K
Sale Common Stock F1, F2 40 $322.00 $13K
Sale Common Stock F1, F2 40 $323.065 $13K
Sale Common Stock F1, F2 40 $315.28 $13K
Sale Common Stock F1, F7, F2 48 $317.3253 $15K
Sale Common Stock F1, F8, F2 182 $317.9626 $58K
Sale Common Stock F1, F9, F2 240 $319.2167 $77K
Sale Common Stock F1, F10, F2 120 $320.0683 $38K
Sale Common Stock F1, F11, F2 80 $322.875 $26K
Sale Common Stock F1, F2 40 $324.76 $13K
Holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 7,500 shares (Indirect, By Caraluna 1 Trust); Common Stock — 7,500 shares (Indirect, By Caraluna 2 Trust); Common Stock — 214,462 shares (Direct)
Footnotes (11)
  1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  2. F2. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
  3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.4100 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.87 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.5200 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.9450 to $320.2600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.62 to $323.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common shares sold 1,500 shares Sales by Caraluna 1 Trust and Caraluna 2 Trust on November 11, 2026
Direct shares held 214,462 shares Reported following the November 11, 2026 transactions
Sale price per share $315.26 per share 40-share sale by Caraluna 1 Trust on November 11, 2026
Sale price per share $324.76 per share 40-share sale by Caraluna 2 Trust on November 11, 2026
Rule 10b5-1 trading plan regulatory
"sale of shares was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"reported price in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NTRA shares did the trusts sell, and when?

Caraluna 1 Trust and Caraluna 2 Trust reported sales totaling 1,500 Natera common shares on November 11, 2026. The sales were made under a Rule 10b5-1 trading plan adopted June 11, 2026.

How many NTRA shares did Jonathan Sheena hold directly after the reported sales?

A separate holding entry lists Jonathan Sheena as directly holding 214,462 shares following the transactions reported on November 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sheena Jonathan

(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100

(Street)
AUSTIN TEXAS 78753

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
CO-FOUNDER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock214,462D
Common Stock11/11/2026S40(1)D$315.268,210Iby Caraluna 1 Trust(2)
Common Stock11/11/2026S85(1)D$316.9256(3)8,125IBy Caraluna 1 Trust(2)
Common Stock11/11/2026S145(1)D$317.8748(4)7,980IBy Caraluna 1 Trust(2)
Common Stock11/11/2026S240(1)D$319.7733(5)7,740IBy Caraluna 1 Trust(2)
Common Stock11/11/2026S160(1)D$320.0188(6)7,580IBy Caraluna 1 Trust(2)
Common Stock11/11/2026S40(1)D$3227,540IBy Caraluna 1 Trust(2)
Common Stock11/11/2026S40(1)D$323.0657,500IBy Caraluna 1 Trust(2)
Common Stock11/11/2026S40(1)D$315.288,210IBy Caraluna 2 Trust(2)
Common Stock11/11/2026S48(1)D$317.3253(7)8,162IBy Caraluna 2 Trust(2)
Common Stock11/11/2026S182(1)D$317.9626(8)7,980IBy Caraluna 2 Trust(2)
Common Stock11/11/2026S240(1)D$319.2167(9)7,740IBy Caraluna 2 Trust(2)
Common Stock11/11/2026S120(1)D$320.0683(10)7,620IBy Caraluna 2 Trust(2)
Common Stock11/11/2026S80(1)D$322.875(11)7,540IBy Caraluna 2 Trust(2)
Common Stock11/11/2026S40(1)D$324.767,500IBy Caraluna 2 Trust(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
2. Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.4100 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5250 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.87 to $320.26 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $316.5200 to $317.4050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $317.56 to $318.31 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $318.8350 to $319.5500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $319.9450 to $320.2600 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.62 to $323.13 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading